Deeptech, HealthTech, High-Tech, Medical Device, Semiconductors, Executive Search / Board, CXO / Chairperson / biometrics

Enhancing Customer Experience in HealthTech with Advanced Biometrics

by Artificial Intelligence ( ai )DeepTechMedical Device & HealthTech

Enhancing Customer Experience with Advanced Biometrics

The convergence of biometrics and customer experience

In HealthTech, trust is currency — and biometrics is fast becoming its most valuable bank.
From medical devices to telehealth platforms, the integration of advanced biometric technology is reshaping how patients, providers, and executives think about security, personalization, and operational efficiency.

For CEOs, Boards, and CXOs in the Medical Device and HealthTech industries, the decision to adopt biometrics is

Deeptech, HealthTech, High-Tech, Medical Device, Semiconductors, Executive Search / Board , CXO / Chairperson

HealthTech: Future Trends

by Artificial Intelligence ( ai )BusinessMedical Device & HealthTech

HealthTech isn’t coming—it’s already here

Digital health is no longer experimental—it’s expected. From AI diagnostics to remote patient monitoring, the HealthTech industry is reshaping how care is delivered, paid for, and experienced. For Boards and CEOs, this is not a peripheral trend. It’s a core shift.

This shift brings opportunity, but also pressure. Growth-stage HealthTech companies must scale while navigating regulatory complexity. Legacy providers must digitize without losing trust. And private equity investors need seasoned executives who can lead innovation without sacrificing operational rigor.

These challenges—succession planning, recruiting visionary CXOs, and aligning leadership with market shifts—are why Executive Search is now a cornerstone of HealthTech strategy.

The future of healthcare won’t be determined by technology alone. It will be led by the CEOs, Chairpersons, and Boards who understand how to deploy it—and by the recruiters who help them find those leaders first.

Why HealthTech Matters for Boards, CEOs, and Investors?

Global HealthTech investment is booming, with market size expected to reach over $900 billion by 2032. But unlike past cycles of healthcare innovation, the current wave is fundamentally reshaping leadership needs at the top.

Today’s CEOs must balance clinical credibility with digital fluency. Boards need to manage risk while pushing innovation. Chairpersons are expected to bring not just governance expertise—but insight into tech-driven care models.

For institutional investors, this means leadership decisions can’t be delayed until after product-market fit. They must begin with it. Without the right CEO or CXO, even the most promising MedTech or HealthTech product won’t cross the commercialization chasm.

According to NextGen’s blog on Scaling MedTech Leadership, “The most successful medical device companies don’t just attract capital—they attract leaders who know how to use it.” Investors now measure value by the strength of the executive bench as much as by the pipeline.

Boards that want to remain competitive in this rapidly changing landscape are engaging executive recruiters early, building succession strategies tailored for AI, robotics, and virtual care, and ensuring that cultural fit doesn’t get lost in the race for innovation.

The Shift To Predictive And Personalized Care

We’re moving from reactive to proactive healthcare. Predictive analytics, wearable sensors, digital biomarkers, and genomics are all fueling a new model of hyper-personalized medicine. The implications for talent acquisition are significant.

As HealthTech evolves toward real-time diagnostics and preventive models, CXOs must adapt. Product leaders are now expected to integrate machine learning. Clinical affairs leaders must navigate FDA frameworks for software-as-a-medical-device. Even finance executives must understand reimbursement models that didn’t exist five years ago.

The result? Traditional candidate pools aren’t enough. Leadership roles now demand hybrid skill sets that span healthcare, data science, and SaaS business models.

Executive Search firms with vertical specialization are best positioned to fill these gaps. They understand the nuance of recruiting a CXO who can lead a digital therapeutic through clinical trials while also scaling a platform across global payer systems.

Talent must match technology. And the companies that hire for where the industry is going—not where it’s been—are the ones that will dominate the future of care.

AI, Automation, and the New CXO Mandate

Artificial intelligence isn’t just disrupting healthcare—it’s redefining what leadership in HealthTech looks like. Clinical AI tools, virtual assistants, and automation platforms are rapidly shifting the operational backbone of care delivery.

This evolution demands a new generation of CXOs.

Chief Operating Officers must now manage human-machine workflows across decentralized teams. Chief Commercial Officers are expected to bring AI-powered CRM insight into go-to-market execution. And perhaps most importantly, CEOs must be comfortable steering companies where algorithms—not physicians—make the first diagnosis.

This level of disruption requires more than technical knowledge. It calls for adaptability, ethical leadership, and fluency in change management.

Retained recruiters are increasingly tasked with identifying leaders who’ve successfully scaled digital health products in AI-first environments. They must assess not only experience but mindset—resilience, agility, and the capacity to guide both clinicians and engineers through transformation.

As discussed in “Learning from Cybersecurity Failures: Best Practices”, digital innovation without governance can expose organizations to risk. The same applies to HealthTech. The new CXO must innovate securely, scale responsibly, and lead with insight.

How Executive Search Drives Innovation In HealthTech

Innovation requires alignment—between vision, execution, and leadership. Executive Search is no longer a support function; it’s a critical lever for accelerating HealthTech success. Recruiters don’t just source candidates. They architect leadership.

Retained executive search firms offer more than access to top-tier candidates. They bring sector-specific intelligence, map competitive leadership moves, and align succession strategies with evolving market needs. More importantly, they understand what HealthTech demands at every stage—whether it’s clinical validation, regulatory strategy, or global commercialization.

In high-growth HealthTech startups, a mis-hire at the CXO level can stall funding, delay product launches, or alienate strategic partners. The right recruiter prevents that by screening for functional capability, leadership style, and cultural compatibility. These aren’t just boxes to tick—they’re success indicators.

In NextGen’s “Strategic Talent Pipelines in Emerging Tech” article, the firm outlines how building future-ready pipelines—before a vacancy occurs—enables growth-stage and PE-backed companies to hire faster, retain longer, and outperform competitors in mission-critical transitions.

If you’re not investing in an executive search partner that understands HealthTech, you may be hiring for yesterday’s challenges instead of tomorrow’s breakthroughs.

Succession Strategies In An Evolving Care Ecosystem

The HealthTech sector has seen record CEO turnover over the past five years. As companies scale and investor expectations rise, succession planning can no longer be postponed. The Chairperson’s responsibility isn’t just to govern—it’s to ensure continuity.

Yet many growth-stage companies have no formal succession strategy in place. This creates gaps during executive transitions, delays in strategy execution, and loss of market confidence.

Succession, in a HealthTech context, must be viewed through the lens of adaptability. Today’s CEO may have guided the company through clinical trials, but the next may need to lead IPO prep, payer negotiations, or M&A integration.

That’s where succession-focused recruiting becomes invaluable. By maintaining an ongoing relationship with a retained executive search firm, companies gain visibility into emerging leadership that matches future needs—not just current roles.

As noted in “Building a Resilient Business in a Rapidly Changing Market”, resilient organizations are built on proactive strategy, not reactive decision-making. And few decisions are more consequential than who leads next.

Talent Shortages, Regulatory Hurdles, And What Recruiters Must Solve

HealthTech recruiting doesn’t happen in a vacuum. It’s shaped by macroeconomic forces, talent shortages, and an ever-tightening regulatory environment.

There is fierce competition for product, clinical, and commercial leaders who understand FDA processes, value-based care models, and international expansion. At the same time, many traditional healthcare leaders struggle to translate their expertise into digital-first environments.

This disconnect creates a vacuum that only strategic recruiters can fill. They must educate Boards on emerging leadership profiles, coach candidates on startup dynamics, and balance innovation with compliance expertise.

Further, with tightening data privacy laws and AI regulations on the rise, recruiters must now evaluate how well CXO candidates navigate governance, cybersecurity, and ethical deployment of patient data. These aren’t future issues—they are present-day obstacles that impact growth.

Retained search partners who specialize in HealthTech are uniquely equipped to bridge these gaps, because they’re tracking the evolving skills matrix in real time and adjusting their search strategies accordingly.

The Board’s Role In Accelerating Healthtech Transformation

HealthTech innovation begins with leadership—but it is scaled through governance. Boards that merely “advise” without strategically shaping talent are missing the point. In fast-growth sectors, Board members are talent accelerators.

Chairpersons must lead the charge in defining the leadership attributes required for next-phase growth—whether it’s digital agility, global expansion experience, or deep payer knowledge. They must ensure the executive team has both depth and diversity in thought and experience.

The Board also plays a crucial role in championing succession. Not just for the CEO, but for every mission-critical position on the executive team. That means advocating for robust performance reviews, identifying emerging internal talent, and building strong relationships with external recruiters.

The companies that lead in HealthTech tomorrow will be those whose Boards today are willing to rethink what leadership looks like—and invest in finding it, not just approving it.

Case Spotlight: Leadership That Scaled Medtech Innovation

One of NextGen’s stories involved a late-stage MedTech company transitioning from regulatory approval to commercial scale. Their original CEO—an engineer by training—was highly respected but lacked experience in market-facing roles.

Rather than risk stagnation, the Chairperson initiated a succession conversation and retained an executive search firm to identify a new CEO who could lead commercial strategy, attract global distribution partners, and communicate investor value.

The firm placed a CEO with a background in both Fortune 500 medical devices and high-growth healthtech startups. Within two quarters, the company doubled its pipeline, secured a strategic partnership with a European hospital group, and exceeded investor forecasts.

This wasn’t luck. It was leadership precision—matching company evolution with executive capability.

In industries where time-to-market defines valuation, having the wrong executive at the wrong time can be fatal. Retained recruiting transforms that risk into opportunity.

Investing In People Is Investing In The Future Of Care

HealthTech will continue to evolve. Technologies will come and go. Regulations will shift. Business models will adapt. But one truth will remain: companies don’t scale innovation—leaders do.

For CEOs, Boards, and Chairpersons looking to future-proof their organizations, Executive Search must move from reactive fill-in-the-gaps thinking to proactive leadership design. Recruiters must be more than vendors—they must be strategic allies.

Whether you’re preparing for succession, entering new markets, or scaling your product pipeline, your competitive edge won’t come from code. It will come from character, clarity, and conviction at the top.

The future of care depends on who leads it.

About NextGen Global Executive Search
NextGen Global Executive Search is a retained firm focused on elite executive placements for VC-backed, PE-owned, growth-stage companies and SMEs in complex sectors such as MedTech, IoT, Power Electronics, Robotics, Defense and Photonics. With deep industry relationships, succession planning expertise and a performance-first approach to recruiting, NextGen not only offers an industry-leading replacement guarantee, they also help CEOs and Boards future-proof their leadership teams for long-term success. They also specialize in confidentially representing executives in their next challenge.

www.NextGenExecSearch.com

CEO / Payment Term Issues / CXO / HealthTech / Semiconductor / Power Electronics / Executive Search / Succession Planning

⏳ CEO’s, When a Trusted Vendor Unilaterally Pushes Payment Terms from 60 to 90 Days…

by BusinessMedical Device & HealthTechPower Electronics & Energy Systems

CEOs, yesterday I had a Confidential call with a President in the Medical Device space and he shared with me a troubling update: a key vendor—long seen as stable and reliable—unilaterally extended payment terms from 60 days to 90 days, without any notice or approval. At face value, it seems like a minor payment delay; but for executives steering companies in Medical Device / HealthTech, Semiconductors and other high-tech industries, it rings alarm bells. Here’s why it’s far more consequential—and how you should respond strategically.

🚩 What This Really Signals

1. Hidden Cash Stress in Your Supply Chain

When a vendor extends terms without consulting you, it’s rarely about generosity—it’s a clear sign they’re managing a cash-flow crisis. They’re effectively using your funds as short-term financing. In sectors like Medical Device / HealthTech, where compliance and FDA regulations demand stability, any sign of financial pressure is a major concern.

2. Trust & Partnership Undermined

Unapproved changes to agreed terms can feel like a breach of trust. Procurement and finance teams consistently report that such shifts often lead to a chilling effect—vendors cut corners, inflate costs, or deprioritize your needs. In semiconductor component sourcing, supply leaders describe the effect bluntly: “They destroyed trust, so we reprioritized orders elsewhere.”

3. Hidden Costs Start to Emerge

While you gain a month of cash flow, vendors will recoup costs elsewhere—via price hikes, expedited-shipping charges, or diluted quality controls. A BCG analysis shows that invoice extensions beyond 15–30 days often result in supplier price increases of 5–8%, erasing any financial gain on your side.

4. Bullwhip Effect Across the Value Chain

Extended payable terms don’t exist in isolation—they reverberate upstream. When sub-suppliers run short, your vendor may delay or shrink your deliveries. Known as the bullwhip effect, this is especially damaging in medical device manufacturing, where a delayed component can halt production lines and disrupt patients downstream.

🛠️ Executive Playbook: What to Do Now

🔎 1. Initiate a Direct, Non-Aggressive Conversation

Start with clarity, not confrontation:

“We noticed a shift from 60 to 90-day terms—could you shed some light on what changed?”

This approach opens dialog without signaling mistrust or putting the vendor on defense. It provides vital context and signals you’re paying attention.

🤝 2. Renegotiate with Value-Added Structures

Flip the conversation to collaborative problem-solving. Consider:

  • Dynamic Discounts: Offer 2% off if paid in 10 days. This aligns FinTech and HealthTech best practices
  • Reverse Factoring / Supply Chain Finance: In partnership with banks or platforms, fund the vendor while retaining your 90-day term. Many major brands (Procter & Gamble, Unilever) maintain cash flow without harming vendor stability
  • Milestone Payments or Escrow: Release payments as work progresses—common in MedTech project launches and semiconductor equipment rollouts

This blend of flexibility and partnership can secure liquidity without damaging incentive structures.

📊 3. Run a Rapid Vendor Health Audit

If terms shifted without conversation, it’s time for a health check:

  • Financial Health: Profit margins, debt ratios, cash flow trajectory
  • Operational Metrics: Delivery times, quality benchmarks, capacity utilization
  • Dependency Risk: How critical are they to your operations? Do you have alternate sources?

In Life Sciences and HealthTech, adding compliance status and regulatory readiness rounds out the risk profile.

🧠 4. Use Data & Digital Tools to Optimize Negotiations

Deploy modern analytics:

  • Supplier Segmentation: Focus on strategic vs. non-critical vendors—don’t blanket apply 90 days
  • GenAI in Negotiation: BCG’s Savings Radar shows that intelligent, segment-specific negotiations outperform across-the-board policies
  • Governance Controls: Finance, procurement, and business units should set thresholds and escalation paths BEFORE extended terms are approved

⚙️ 5. Activate Contingency & Dual-Sourcing Plans

If a vendor’s unilateral actions continue or signs of distress mount, initiate your backup:

  • Backup Supplier Onboarding: Even low-cost secondary suppliers help mitigate sudden failures
  • Inventory Buffers: For mission-critical components, hold 4–6 weeks of stock—as is common in regulated medical device production

📈 6. Monitor the Long-Term Strategic Relationship

Elevate metrics in your supplier scorecards:

  • Payment Behavior: Timeliness versus contracted terms
  • Response to Negotiation: Willingness to engage, flexibility, communications
  • Operational Consistency: On-time delivery rates, defect rates, responsiveness

Revisit vendor status quarterly—or trigger ad-hoc reviews if terms shift again without communication.

🧭 What This Says About Your Leadership

Successfully navigating this situation signals:

  • Strategic Maturity: You’re protecting Working Capital and supply chain resilience
  • Partner-Oriented Leadership: You’re collaborative, yet firm—defining value, not just extracting it
  • Governance Strength: Your team anticipates risk and responds before it spikes

In industries like Medical Device, where patient safety is tied to raw materials and components, these traits preserve organizational integrity—and patient trust.

🔄 Real-World Examples & Benchmarks

  • A chemical firm extended terms by 60 days across 200 suppliers and combined the change with financing programs—55% vendor participation with no disruptions
  • Retail giants like P&G and Kellogg extended terms to 90–120 days during COVID-19; those that offered integrated financing kept supplier performance intact
  • However, companies that unilaterally demanded term extensions without support faced supplier exits, contract cancellations, or legal pushback

✅ Final Takeaway for Life Science & HealthTech Execs

A vendor stretching your terms from 60 to 90 days without your knowledge is more than a payment delay—it’s a strategic alarm bell. It signals:

  • Vendor liquidity risk
  • Potential downstream disruptions
  • Erosion of trust and partnership dynamics

Your response must balance demand with support, discipline with empathy, and always align with long-term supply chain integrity.

By combining informed conversation, flexible finance tools, dual sourcing, and governance frameworks, executive teams can maintain both operational uptime and strategic advantage.

🎯 Your Call-to-Action

Want to master vendor resilience in Medical Device or HealthTech manufacturing?

  1. Create a Vendor Health and Payment Terms Audit Toolkit
  2. Create templates for Dynamic Discount & Supply Chain Finance structures
  3. Create Governance framework used by top-tier Life Science procurement teams

Feel free to message me or connect directly for a confidential conversation.

_____________________________________________________________

About NextGen Global Executive Search
NextGen Global Executive Search is a retained firm focused on elite executive placements for VC-backed, PE-owned, growth-stage companies and SMEs in complex sectors such as MedTech, IoT, Power Electronics, Robotics, Defense and Photonics. With deep industry relationships, succession planning expertise and a performance-first approach to recruiting, NextGen not only offers an industry-leading replacement guarantee, they also help CEOs and Boards future-proof their leadership teams for long-term success. They also specialize in confidentially representing executives in their next challenge.

www.NextGenExecSearch.com

CEO / CXO / VP / Medical Device / HealthTech / DeepTech / Semiconductor / Defense / IoT / Executive Search / Succession Planning

CXO’s Learning from Cybersecurity Failures: Best Practices

by Data SecurityMedical Device & HealthTechSuccession Planning

CXOs, Cybersecurity failures in healthcare aren’t just breaches of data—they’re breaches of trust.
In the Medical Device and HealthTech sectors, one misstep can compromise patient safety, trigger regulatory intervention, and erase millions in market value overnight.

What’s more alarming? Many of these failures stem from leadership blind spots—not technological limitations.

Boards and CEOs are waking up to a sobering reality: cybersecurity is no longer a function relegated to IT. It’s a core part of governance, risk strategy, and even brand protection. And in a post-breach world, it’s also a direct reflection of executive competence.

“In healthcare, cybersecurity isn’t an IT issue—it’s a boardroom issue.”

The High Cost of Weak Links in HealthTech

Recent high-profile breaches across hospital networks, diagnostic platforms, and implantable medical devices reveal a consistent pattern: reactive infrastructure, fragmented data protection policies, and siloed decision-making. The damage isn’t theoretical.

In 2023, a ransomware attack on a U.S.-based digital therapeutics company halted services for two weeks and led to the resignation of its CEO. Investor confidence plummeted. More importantly, patient care continuity was disrupted.

The HealthTech ecosystem is inherently vulnerable—reliant on interconnected devices, cloud-based EMRs, remote monitoring systems, and AI-driven diagnostics. Every endpoint is a potential entry point. Every delay in leadership action is a liability.

Boards overseeing high-growth MedTech firms are increasingly recognizing that unprotected innovation is unsustainable. They’re shifting from compliance-based thinking to resilience-based planning.

“In MedTech, the attack surface expands with every breakthrough.”

From the OR to the C-Suite: Accountability Starts at the Top

Cybersecurity used to be a line item in IT budgets. Today, it’s a line of inquiry in investor calls and FDA reviews. Leadership teams can no longer afford to defer cyber risk down the hierarchy.

Smart CEOs now embed cybersecurity into executive planning—treating it not as a tech project, but a strategic function alongside product development and go-to-market execution.

For Boards, this means asking new questions during quarterly reviews:

  • Who owns cybersecurity at the executive level?
  • Is the CISO part of leadership discussions, or isolated under infrastructure?
  • Are digital risks modeled in M&A scenarios and clinical deployment timelines?

Cyber risk is enterprise risk. And failure to lead on this front is fast becoming a disqualifier in executive search.

As one HealthTech investor recently put it: “If your CEO can’t speak fluently about cybersecurity posture, we don’t view them as fit for scale.”

“Leadership is the first layer of defense—and the first point of failure.”

The Role of Executive Search in Cyber-Ready Leadership

The evolving threat landscape has permanently changed the mandate for executive hiring in Medical Device and HealthTech. Cyber literacy is no longer a “nice-to-have”—it’s table stakes.

Today’s executive search firms like NextGen Global are redefining candidate Profiles for critical roles like Chief Executive Officer, Chief Technology Officer, and Chief Operating Officer. Recruiters now benchmark not just operational outcomes, but digital risk awareness, regulatory alignment, and incident response experience.

The market has spoken. Companies want leaders who can navigate complex compliance requirements (HIPAA, MDR, GDPR), lead during security crises, and partner effectively with CISOs and privacy counsel.

This shift has redefined recruiting priorities. It has also exposed a gap: traditional healthcare leaders often lack cyber fluency, while seasoned tech leaders may lack sector-specific sensitivity.

How to hedge against executive search firms in todays marketplace? Gauge them on their Replacement Guarantee. If they only offer a 6-12 month guarantee, this should be a Red Flag they are not confident in their candidates.

Top-tier recruiters help bridge that gap—identifying hybrid leaders who blend technical literacy with patient-centered discipline. These aren’t common profiles, but they are increasingly non-negotiable.

“The next wave of HealthTech growth depends on leaders who understand both compliance and code.”

Succession Planning Amid Digital Threats

Succession planning in healthcare is complex enough. But when digital infrastructure is added to the equation, stakes rise exponentially.

What happens when a cyber incident forces an early leadership exit? Or when new privacy regulations require a shift in executive oversight? Without succession plans that account for digital readiness, organizations risk continuity breakdowns during high-pressure events.

Boards must now evaluate not just readiness to lead—but readiness to secure. That means auditing the digital risk posture of internal successors, vetting external candidates for security competence, and building transition frameworks that don’t rely on a single point of failure.

Retained executive search partners are playing a vital role in this evolution. The most progressive firms embed security assessments into succession pipelines, ensuring that future leaders are prepared to operate in a world where threat actors are as sophisticated as competitors.

In a landscape defined by disruption, succession is no longer about replacement—it’s about resilience.

“In HealthTech, the next CEO must be as cyber-capable as they are clinically competent.”

HealthTech Talent Gaps: The Silent Risk Vector

Behind every cybersecurity breach is a leadership gap—specifically in talent that bridges medical innovation and digital defense. HealthTech companies report that more than 60% of cyber incidents stem from a lack of executive cyber fluency. That’s not a technology problem—it’s a recruiting problem.

The shortage hits hardest at the C-level, where teams need leaders who can speak both clinical outcomes and cybersecurity protocols. Without hybrid CXOs, companies lean too heavily on technology vendors—and lose sight of risk ownership.

Today’s top-performing firms are working with their executive search partners to address this. They’re not just hiring CISOs—they’re recruiting for digital culturists who can structure multidisciplinary leadership teams and accelerate maturity across every product release.

“In HealthTech, talent gaps aren’t just blind spots—they’re attack vectors.”

Case Studies: When Cyber Failures Erode Trust and Market Share

Industry headlines don’t always show the full cost of cybersecurity failures—they only tell half the story.

One MedTech firm saw its CEO exit and market cap drop 25% in just one week after a connected diagnostic device was compromised. Another HealthTech scale-up faced two FDA safety mandates and board-level investigations after failing to secure remote telemetry systems. In both instances, background checks and cyber-readiness were afterthoughts in leadership design.

These failures led to investor lawsuits, delisting warnings, and the departure of entire CXO teams. They weren’t just technical breakdowns—they were succession and governance breakdowns.

The lesson? Cyber incidents escalate quickly when leadership and risk are out of sync. CEOs, Boards, and Search Partners must use these case studies not as warnings—but as operating guides.

“Lessons aren’t learned—they’re earned—and sometimes painfully.”

Building Cyber Resilience into the Executive Layer

Cyber resilience isn’t built in IT computer rooms—it’s built in boardrooms and leadership ICPs (Individual Cyber Plans).

Resilience starts with executive mandates. Today’s best-in-class CEO charters include defined cyber metrics—PCI maturity, incident response times, data integrity KPIs—and performance is evaluated accordingly.

Executive Search plays a vital role in embedding these expectations by identifying leaders who have operated under regulatory pressure, guided clinical cyber rollouts, and led breach responses without brand collapse.

Companies are structuring dual-lead roles—like CISO plus CTO teaching sessions—to create shared ownership and redundancy. They’re training C-level executives on entity-level cybersecurity, embedding it into succession planning and leadership performance scorecards.

Boards are beginning to see that a cyber resilient executive team doesn’t just protect value—it multiplies it.

“Cyber resilience is a leadership capability—not just a technical outcome.”

Secure Systems Start with Secure Leadership

The most sophisticated medical devices and HealthTech platforms can still fail when leadership fails to lead. Cybersecurity isn’t a software checkbox anymore—it’s a test of governance strength, recruiting discipline, and succession readiness.

In regulated sectors, Boards and CEOs must treat cybersecurity as an executive risk—not just a technical one. This means hiring leaders who are cyber literate, embedding security into succession, and partnering with executive recruiters who understand the convergence of technology, compliance, and strategy.

Every security metric reported to the FDA, every feature in your next release, and every clinical endpoint relies not just on code, but on capable leadership.

“Secure systems start with secure leadership—not happenstance technology.”

_______________________________________________________________________________________

About NextGen Global Executive Search
NextGen Global Executive Search is a retained firm focused on elite executive placements for VC-backed, PE-owned, growth-stage companies and SMEs in complex sectors such as MedTech, IoT, Power Electronics, Robotics, Defense and Photonics. With deep industry relationships, succession planning expertise and a performance-first approach to recruiting, NextGen not only offers an industry-leading replacement guarantee, they also help CEOs and Boards future-proof their leadership teams for long-term success. They also specialize in confidentially representing executives in their next challenge.